1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Gold Nanoparticles Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Gold Nanoparticles Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. COVID-19 Pandemic Impact on Industry
6. Gold Nanoparticles Market Analysis and Forecast, by Application
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Application, 2023–2031
6.3.1. Imaging
6.3.2. Targeted Drug Delivery
6.3.3. Proton Therapy
6.3.4. In-Vitro Assays
6.3.5. Sensors
6.3.6. Probes
6.3.7. Catalysis
6.3.8. Other Applications
6.3.9. 6.4 Market Attractiveness, by Application
7. Gold Nanoparticles Market Analysis and Forecast, by End-user
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2023–2031
7.3.1. Healthcare
7.3.2. Electronics
7.3.3. Chemicals
7.3.4. Others
7.4. Market Attractiveness, by End-user
8. Gold Nanoparticles Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2023–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region
9. North America Gold Nanoparticles Market Analysis and Forecast
9.1. Market Value Forecast, by Application, 2023–2031
9.1.1. Imaging
9.1.2. Targeted Drug Delivery
9.1.3. Proton Therapy
9.1.4. In-Vitro Assays
9.1.5. Sensors
9.1.6. Probes
9.1.7. Catalysis
9.1.8. Other Applications
9.2. Market Attractiveness, by Application
9.3. Market Value Forecast, by End-user, 2023–2031
9.3.1. Healthcare
9.3.2. Electronics
9.3.3. Chemicals
9.3.4. Others
9.4. Market Attractiveness, by End-user
9.5. Market Value Forecast, by Country, 2023–2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Application
9.6.2. By End-user
9.6.3. By Country
10. Europe Gold Nanoparticles Market Analysis and Forecast
10.1. Market Value Forecast, by Application, 2023–2031
10.1.1. Imaging
10.1.2. Targeted Drug Delivery
10.1.3. Proton Therapy
10.1.4. In-Vitro Assays
10.1.5. Sensors
10.1.6. Probes
10.1.7. Catalysis
10.1.8. Other Applications
10.2. Market Attractiveness, by Application
10.3. Market Value Forecast, by End-user, 2023–2031
10.3.1. Healthcare
10.3.2. Electronics
10.3.3. Chemicals
10.3.4. Others
10.4. Market Attractiveness, by End-user
10.5. Market Value Forecast, by Country/Sub-region, 2023–2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Gold Nanoparticles Market Analysis and Forecast
11.1. Market Value Forecast, by Application, 2023–2031
11.1.1. Imaging
11.1.2. Targeted Drug Delivery
11.1.3. Proton Therapy
11.1.4. In-Vitro Assays
11.1.5. Sensors
11.1.6. Probes
11.1.7. Catalysis
11.1.8. Other Applications
11.2. Market Attractiveness, by Application
11.3. Market Value Forecast, by End-user, 2023–2031
11.3.1. Healthcare
11.3.2. Electronics
11.3.3. Chemicals
11.3.4. Others
11.4. Market Attractiveness, by End-user
11.5. Market Value Forecast, by Country/Sub-region, 2023–2031
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Gold Nanoparticles Market Analysis and Forecast
12.1. Market Value Forecast, by Application, 2023–2031
12.1.1. Imaging
12.1.2. Targeted Drug Delivery
12.1.3. Proton Therapy
12.1.4. In-Vitro Assays
12.1.5. Sensors
12.1.6. Probes
12.1.7. Catalysis
12.1.8. Other Applications
12.2. Market Attractiveness, by Application
12.3. Market Value Forecast, by End-user, 2023–2031
12.3.1. Healthcare
12.3.2. Electronics
12.3.3. Chemicals
12.3.4. Others
12.4. Market Attractiveness, by End-user
12.5. Market Value Forecast, by Country/Sub-region, 2023–2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Gold Nanoparticles Market Analysis and Forecast
13.1. Market Value Forecast, by Application, 2023–2031
13.1.1. Imaging
13.1.2. Targeted Drug Delivery
13.1.3. Proton Therapy
13.1.4. In-Vitro Assays
13.1.5. Sensors
13.1.6. Probes
13.1.7. Catalysis
13.1.8. Other Applications
13.2. Market Attractiveness, by Application
13.3. Market Value Forecast, by End-user, 2023–2031
13.3.1. Healthcare
13.3.2. Electronics
13.3.3. Chemicals
13.3.4. Others
13.4. Market Attractiveness, by End-user
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. BBI Solutions
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. TANAKA
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Johnson Matthey Plc
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Nanopartz Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Nanocomposix Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Meliorum Technologies, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Sigma Aldrich
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Innova Biosicences
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Cline Scientific
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Cytodiagnostics
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/